Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you evaluate and constrain the cumulative lung DVH for inoperable patients who have received multiple courses of lung SBRT and now require fractionated mediastinal RT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Premiere Radiation Oncology

This is an increasingly common problem and there are few data to guide decision making.However, some have looked at dosimetric-toxicity relationships in the reirradiation setting (either re-SABR or conventional radiation after SABR).It's suggested that composite high dose to a previously irradiated ...

Do you do a CT simulation for post op heterotopic ossification prophylaxis?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · VA New Jersey Healthcare System - East Orange campus.

Yes, we treat a fair amount of HO cases at our institution in NJ, and in most cases, at least that I know of, we have always obtained CTs for planning. Honestly, because the anatomy is so straightforward in the hip area to be treated, just plain 2D imaging will suffice. In the old school way, we use...

Would you treat unfavorable intermediate risk prostate cancer in the setting of recently resected NSCLC?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Case Western Reserve University/ University Hospitals Seidman Cancer Center

This greatly depends on the stage of the lung cancer. If stage IIIA resected NSCLC, I would not treat the prostate cancer immediately, and effectively enter them into active surveillance until the patient is 2 years free of NSCLC on follow-up imaging. If they recur from NSCLC within 2 years, they ha...

Would you include the regional nodes when treating with PMRT in a patient with a high grade, large primary tumor, but low burden axillary disease with a complete axillary dissection (e.g. 1/20 nodes involved)?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

This is a question we are seeing more and more. I break these cases down into two situations: 1. Postmastectomy, no neoadjuvant: In these cases, I extrapolate from MA20 which looked at patients undergoing breast conservation with ALND and a large percentage had low nodal burdens. RNI was associated ...

How long after prostate radiation do you recommend waiting for routine screening colonoscopy?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · VA New Jersey Healthcare System - East Orange campus.

Good question. In this regard, I would say that the timing would depend on the nature of the acute reaction in the area of the rectum adjacent to the prostate. This may be patient dependent. Further, the local reaction erythema can last for weeks to months depending on the reaction. Also, if it's >1...

How do you manage limited intracranial disease from a metastatic large cell neuroendocrine tumor?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Roswell Park Comprehensive Cancer Center

In our practice we are moving to focal management of limited intracranial disease for all pathologies, pushing WBRT out to last resort status.LCNEC is a heterogeneous disease (Hiroshima K, Mino-Kenudson M. Transl Lung Cancer Res. 2017) with variable response to chemo therapy. Even more unclear is it...

Which criteria do you follow to recommend low-dose CT screening in patients at high risk for lung cancer?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Cedars-Sinai Medical Center

At this time, I still follow the USPSTF/NLST guidelines, but believe the criteria for screening should be updated to include more patients. The current recommendations from the USPSTF based on the National Lung Screening Trial demonstrating an improvement in lung cancer and all cause mortality inclu...

Are there specific radiographic features that would alter your management of a presumed meningioma?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

This question is particularly relevant for a patient who has a history of a cancer and a dural-based lesion that may represent metastasis or meningioma. Edema, as @Dr. First Last related, may suggest atypical histology. Necrosis may suggest a more malignant tumor, including malignant meningioma or d...

How would you manage a patient needing PMRT with a history of severe burn to the chest?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

In these cases, its important to consider risk and benefit. I would also discuss with the plastic surgeon with respect to skin flap. If the patient has advanced disease, I would offer PMRT, but counsel patient on increased toxicity risk and risk of infection. I would try to quantify improvement in l...

What is the effect of IV contrast on dosimetry for thoracic RT planning?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

The requirement for a non-contrast CT or manual region overrides of HU prior to calculation for lung IMRT was the subject of much debate when I came to Wash U. So, we ran a simple prospective trial where we scanned 8 patients with and without contrast.Intuitively, contrast scans provided better targ...